Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke (Q43130723)

14 November 2017

Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke (English)

1 reference

14 November 2017

1

Peter M Rothwell

1 reference

14 November 2017

Sally C Howard

2

1 reference

14 November 2017

Eamon Dolan

3

1 reference

14 November 2017

Eoin O'Brien

4

1 reference

14 November 2017

Joanna E Dobson

5

1 reference

14 November 2017

Bjorn Dahlöf

6

1 reference

14 November 2017

Neil R Poulter

7

1 reference

14 November 2017

Peter S Sever

8

1 reference

14 November 2017

ASCOT-BPLA and MRC Trial Investigators

9

1 reference

14 November 2017

11 March 2010

1 reference

14 November 2017

1 reference

14 November 2017

9

1 reference

14 November 2017

5

1 reference

14 November 2017

469-480

1 reference

Global burden of blood-pressure-related disease, 2001.

14 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Blood pressure reduction is not the only determinant of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Regression dilution of systolic and diastolic blood pressure in patients with established cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Medium-term variability of blood pressure and potential underdiagnosis of hypertension in patients with previous transient ischemic attack or minor stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970066-1

7 January 2021

10.1016/S1474-4422(10)70066-1

Identifiers

DOI

1 reference

release_uec7fjdmq5dqzbyjzrwdy7zlxe

14 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uec7fjdmq5dqzbyjzrwdy7zlxe

24 November 2022

mapped directly with Wikidata item

1 reference